Diez futures medical therapies that will be available in 2020 to help

Latina Medical News and Public Health Agency
With the information from: Redacción Médica

The best doctors and investigators in the clinical clinic, Cleveland Clinic, he compiled a list of the 10 most important medical innovations for 2020. A review of advances with “power to transform medical attention” that from a medication for osteoporosis of double action or the use of acidic acid for the cholesterol reduction in intolerant patients to the statins.

This list contains the final brochure of the 2019 Medical Innovation Cumber that celebrated its 17th anniversary and was coordinated by the expert Michael Roizen, director of Bienestar Emeritus of the Cleveland Clinic. The specialist assured that, in addition to transforming “Significantly the medical campThese innovations “increase the attention of patients all over the world”.

Drug for osteoporosis of double action

La osteoporosis it is an affection in which the huesos become debilitated and become fragile vuelven, which increases their risk of fracture. With osteoporosis, the loss of a healthy, progressive and progressive manner in menopause without sinuses is the first fracture. ‘N Proportionate a mayor power of oseo fortification, the recent FDA approval of a new double action drug (romosozumab) is given to patients with osteoporosis more control to prevent additional fractures.

Uso amplified by the minimally invasive mitral valve surgery

La válvula mitral allows the blood to flow from the aortic aneurysm of the coronary artery to the ventricular ventricle. Approximately 1 in every 10 patients majored in 75 years, the mitral valve is defective and causes the action of regurgitation. Amplify the approval of a device of recovery valve minimally invasive to a population of patients that he has not logged in will alleviate the symptoms of other therapies proportion a new important treatment option.

Treatment for amirloid amyloid myocardiopathy

El cardiovascular disorders ATTR-CM is a progressive, slightly diagnosed and potentially lethal disease in which amyloid protein fibrillation is deposited and resurfaced. ventricular ventricle of the heart. But a new agent to prevent the wrongful payment of the protein deposited must have a significantly lower risk of death. After the Fast-Track and Breakthrough designs in 2017 and 2018, 2019 marked the FDA’s approval of tafamidis, the first drug to treat this affection any more.

Therapy for allergies to cockroaches

The 2.5 per cent of the fathers corren the risk of which at any moment his hive can not breathe debt to a allergic reaction. Although the emergence epinephrine has reduced pregnancy and the risk of accidental exposure, these innovations are not enough to soothe the ever-present. For this, the best panel of experts has the innovator the development of a new oral immunotherapy drug to gradually develop the tolerance to exposure to cockroaches.

5. Estimation of the spinal medium in the closed circuit

Chronic pain is a terribly frustrating condition and a great reason for prescribing opioid drugs. The estimation of the spinal medium is a gewilde treatment for the chronic pain traversed by the cual an implantable proportions proportion a electrical estimate of the spinal medium. Pero the unsatisfactory results debit to subtherapeutic events or sobreestimulation its communes. Circular estimation allows for more communication between the device and the spinal medium, which proposes an estimation and a maximum optimization rate.

Biological products in orthopedic repair

After orthopedic surgery, the body can be delayed between months and years in recovery. For biological products (cellulose cells, blood components and hormones) have the power to replace or approve the power of the body and promote the cure. These elements are related to orthopedic attention, which allow the probability of better results accelerated.

An antibiotic for the prevention of infections through the implantation of cardiac devices

All over the world, 1.5 million cardiac electronic devices are being implanted. In these patients, the infection becomes an important and potentially fatal complication. The sobbing embebidos in antibiotics now stands to encapsulate these cardiac devices, preventing effective infection.

Bempedoic acid for the reduction of cholesterol in patients unbearable in the patients

Cholesterol alto is an important preoccupation for cases over 40 per cent of adults in the EE. UU. If it is not treated, the affection may provoke health-graft problems, as cardiac attack and cerebrovascular accident. Although they generally deal with statins, some people experience an unacceptable amount of muscle with them. The bempic acid proportions have an alternative effect to reduce LDL cholesterol while avoiding these secondary effects.

PARP inhibitors for maintenance therapy in ovarian cancer

The inhibitors of PARP or the poly-ADP ribose polymer block the repair of the DNA given in the tumor cells, which increase cellular death, especially in tumors with deficient repair mechanisms. One of the most important advances in the treatment of ovarian cancer, the PARP inhibitors increased free progression surveillance and now are being approved for first-line maintenance therapy in advanced stage nursing. Various additional therapies are being performed with a large number of inhibitors of PARP to establish great advances in the majority of results in anti-cancer therapy.

Medicines for cardiac insufficiency with preserved ejection fraction

Cardiac insufficiency with preserved ejection fraction (HFpEF), also known as diastolic cardiac insufficiency, is the affection in which the ventricular coronary muscles contract normally, but are not related to debridement. With the preservation of the preserved ejection, the coronation can not be leached adequately of blood, leaving less available for bomber al cuerpo. Currently, the recommendations for this treatment are directed at accompanying affections and at the level of the symptoms. For SGLT2 inhibitors, a class of drugs used in the treatment of type 2 diabetes, exploring HFpEF, introducing a possible new treatment option.